CHASE MITCHELL: Open Payments
NPI 1841605268 · OGDEN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$312 in 14 payments from 12 companies in 2025. Trend: 2023 $417 · 2024 $279 · 2025 $312
Food & beverage: $312
| Company | Payments | Amount |
|---|---|---|
| Solventum Corporation | 2 | $61 |
| Novo Nordisk Inc | 2 | $32 |
| Zimmer Biomet Holdings, Inc. | 1 | $31 |
| MOXIMED, INC | 1 | $27 |
| Vericel Corporation | 1 | $24 |
| Alafair Biosciences, Inc. | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Stryker Corporation | 1 | $22 |
| Endo USA, Inc. | 1 | $19 |
| Seqirus USA Inc | 1 | $17 |
Products named: PREVENA, Tapestry, MISHA KNEE SYSTEM, SMALL, LEFT, MACI, VersaWrap, ROTATEQ, GAMMA, XIAFLEX.
Industry payments across UT — which companies pay providers there.
